Sherif S. Farag
- Titled Professor (2013)
- Lawrence H. Einhorn Professor of Oncology
Indiana University Purdue University Indianapolis (IUPUI)
School of Medicine
Department of Medicine
BIOGRAPHYSherif Farag, professor of medicine and researcher with the IU Simon Cancer Center, is associate director for clinical research at the cancer center. He is responsible for the overall direction and development of the cancer center's clinical research program, for recognizing promising areas of research and for providing direction to faculty in pursuing research objectives.
Dr. Farag is also director of the Hematological Malignancies Program and the Bone Marrow and Stem Cell Transplantation Program at the cancer center.
As a member of the Hematopoiesis, Malignant Hematology, and Immunology research program at the IU Simon Cancer Center, Dr. Farag focuses his research on the development of novel approaches to hematopoietic stem cell transplantation, including safer approaches to alternate donor transplantation.
He also is focused on the development of novel agents and regimens for the treatment of multiple myeloma, including preclinical research of new drug development.
Certified in internal medicine, clinical hematology and hematopathology by the Royal Colleges of Physicians and Pathologists in Australia, Dr. Farag is an active member of the American Society of Clinical Oncology, the American Society of Hematology, the American Society for Blood and Marrow Transplantation and the International Society for Cellular Therapy, among others. He also served as a panel member of the National Comprehensive Cancer Network for Multiple Myeloma.
A graduate of the University of Melbourne with a bachelor's degree in medicine and bachelor's degree in surgery as well as a doctor of philosophy in medicine, Dr. Farag completed his residency training at the Royal Melbourne Hospital in internal medicine. He completed a fellowship in clinical hematology at St. Vincent's Hospital in Melbourne and additional training in bone marrow transplantation at Roswell Park Cancer Institute in Buffalo, N.Y.